title: The epidermal growth factor receptor D761Y mutation and effect of tyrosine kinase inhibitor.
authors.forename: Shinichi
authors.initials: S
authors.lastname: Toyooka
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Date
authors.forename: Akiko
authors.initials: A
authors.lastname: Uchida
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Kiura
authors.forename: Minoru
authors.initials: M
authors.lastname: Takata
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics*; D000970:Antineoplastic Agents / Q000494:pharmacology; D002460:Cell Line; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000235:genetics*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics*; D011799:Quinazolines / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib